Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Seres Therapeutics, Inc. (MCRB) had Gross Margin of 100.00% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$126.33M |
|
$-113.72M |
|
-- |
|
$126.33M |
|
$234.31M |
|
$-107.98M |
|
$-5.74M |
|
$-113.72M |
|
$-113.72M |
|
$-113.72M |
|
$-113.72M |
|
$-113.72M |
|
$-113.72M |
|
$-107.98M |
|
$-100.84M |
|
128.00M |
|
128.00M |
|
$-0.89 |
|
$-0.89 |
|
| Balance Sheet Financials | |
$175.41M |
|
$22.46M |
|
$183.19M |
|
$358.60M |
|
$98.66M |
|
$101.54M |
|
$304.80M |
|
$403.46M |
|
$-44.86M |
|
$-44.86M |
|
$-44.86M |
|
135.04M |
|
| Cash Flow Statement Financials | |
$-117.35M |
|
$10.58M |
|
$71.70M |
|
$171.22M |
|
$136.15M |
|
$-35.07M |
|
$34.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.78 |
|
-- |
|
-- |
|
1.79 |
|
-2.26 |
|
|
Gross Margin |
100.00% |
-85.48% |
|
-85.48% |
|
-79.82% |
|
-90.02% |
|
-90.02% |
|
$-125.33M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
-- |
|
14.56 |
|
25.06 |
|
253.53% |
|
253.53% |
|
-31.71% |
|
-200.61% |
|
$-0.33 |
|
$-0.98 |
|
$-0.92 |
|